Print

Lay Description

Create a living biobank of PDOs from Stage I-III lung cancer patients.

Category

  • Cancers and Other Neoplasms
  • Lungs, Breathing and Bronchial
  • Lung
IRB Number
20180485HU
NCT Number
NCT03655015
Open to Enrollment
Yes

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Read, consented to and signed the IRB-approved informed consent form prior to any study related procedure.
  • Diagnosis of lung cancer or lung mass or lymphadenopathy that will undergo tumor resection as part of standard of care
  • Any clinical stage
  • Adult patients ≥18 years of age
  • Able and willing to complete a questionnaire on their environmental/occupational exposures and smoking/alcohol history

Exclusion Criteria

  • At the discretion of the treating physician, patient will not be able to fulfill the requirements of the study.

Study Design

Arm Groups

Study Contact

Frances Crawford
(210) 450-5037
crawfordf1@uthscsa.edu

Sonia Creighton
(210) 450-1366
creighton@uthscsa.edu

Myrna Montenegro
(210) 450-5954
montenegro@uthscsa.edu

Courtney Nichols
(210) 450-1794
nicholsc2@uthscsa.edu

Mailbox Ctrc Regulatory Affairs
regaffapp@uthscsa.edu

Kathleen Rodriguez
(210) 450-1365
rodriguezk3@uthscsa.edu

Benjamin Schleif
(210) 450-1366
schleifb@uthscsa.edu

Morgan Seekatz
(210) 450-1133
seekatz@uthscsa.edu

Josephine Taverna
tavernaj@uthscsa.edu

Principal Investigator
Josephine Taverna